New research shows that the presence of amyloid and tau proteins in the blood may be an easier and more accurate way to diagnose AD—not to mention, less expensive and more accessible to patients who are unable to get costly, and sometimes painful, diagnostic procedures.
www.healthcentral.com
This is a virtual and in-person course offered in association with the American Stroke Association, New York City. This course provides a yearly comprehensive review of the fi eld of cerebrovascular disease and covers epidemiology, diagnosis, acute management, secondary prevention, and rehabilitation. All healthcare providers are welcome.
In a new study in JAMA Neurology, Dr. Hooman Kamel and colleagues found that the short-term risk of a second stroke following an initial minor stroke is about 60 percent higher among African American patients than white patients. Analyzing data gathered previously for a large clinical trial, the team noted that roughly 8 percent of the African American patients suffered new strokes within the high-risk period following their initial stroke, compared with only 5 percent of the white...
At the American Stroke Association’s International Stroke Conference in Los Angeles, Dr. Neal Parikh presented preliminary research into smoking rates among stroke survivors. After examining data from more than 49,000 adults who participated in the National Health and Nutritional Examination Surveys between 1996 and 2016, the researchers found that while the percentage of smokers in the overall population has declined steadily, smoking among stroke survivors has remained steady. Parikh notes...
